ArticleFrontiers in ophthalmology2022

Case Report: Serial changes of ocular complications related to immune checkpoint inhibitors pembrolizumab and nivolumab.

Wan-Hua Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.